BRAIN Biotech AG

BNN

Company Profile

  • Business description

    BRAIN Biotech AG is an industrial biotechnology specialist focused on enzyme technology, microbial production strains, and bioprocess design to enable bio-based innovations. The Group conducts research, development, and production for client specifications and its own product portfolio, supporting customers in the food and beverage, chemical, and life sciences industries with solutions that enhance productivity, efficiency, and sustainability. Its operations are organized into two segments: BRAIN Biocatalysts, which develops, produces, and distributes specialty enzymes, microorganisms, and ingredients and generates the majority of revenue, and BRAIN BioIncubator, which focuses on development projects. The company operates in Germany and other countries.

  • Contact

    Darmstadter Strasse 34-36
    ZwingenbergBW64673
    DEU

    T: +49 62519331

    https://www.brain-biotech.com

  • Sector

    Basic Materials

    Stock type

    Cyclical

  • Industry

    Specialty Chemicals

    Fiscal Year End

    30 September 2026

    Employees

    264

Stocks News & Analysis

stocks

This ASX miner is the cheapest in our iron ore coverage

High debt levels and low commodity prices were a concern, but agreed sell-downs and a ramp-up of key operations should help.
stocks

Apple names new CEO as Tim Cook steps aside after 15 years

John Ternus, Apple’s hardware chief, will take up the role in September.
stocks

Updating our commodity price assumptions

Our view as China’s steel production drops.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries9,074.4050.80-0.56%
CAC 408,156.4379.28-0.96%
DAX 4024,194.9075.97-0.31%
Dow JONES (US)49,490.03340.650.69%
FTSE 10010,476.4621.63-0.21%
HKSE26,163.24324.24-1.22%
NASDAQ24,657.57397.601.64%
Nikkei 22559,585.86236.690.40%
NZX 50 Index12,991.5745.970.36%
S&P 5007,137.9073.891.05%
S&P/ASX 2008,843.6053.20-0.60%
SSE Composite Index4,106.2621.180.52%

Market Movers